Formulary Monographs [BUDESONIDE|FORMOTEROL, 4892]
|
|
BUDESONIDE | FORMOTEROL
|
|
|
|
|
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
Treatment of asthma.
|
|
|
Beta blockers including eye drops can weaken the effect of the inhaler. Ketoconazole may increase systemic exposure to the budesonide component. Use with caution in patients with cardiovascular disease, diabetes, untreated hypokalemia or thy rotoxicosis. Data on use in pregnancy and breast feeding are unavailable. Headache, palpitations, tremor, candida infection in the oropharynx, mild throat irritation, coughing, hoarseness. Dosage is individual according to disease severity . Titrate to lowest dose when control is achieved. Not recommended in children under 12 yrs.
|
|
|
Adults and Children 12 years and older: 1-2 inhalations once or twice daily . See BDS supply protocols pg. 10.
|
|
|
|
|
|
|
|
|
|
|
|
|